Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have received an average rating of “Moderate Buy” from ...

Five things you need to know in local business news to start your workday, including how Monday's stock market rout shaved $21 billion off five Massachusetts companies, plus more MGB layoffs, a ...

Atria Investments Inc significantly reduced its stake in Regeneron Pharmaceuticals by 20.2% in the fourth quarter. Despite ...

Stock analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of Atea Pharmaceuticals in a research report issued on Friday, March 7th. William Blair analyst A.